ABIO ARCA biopharma, Inc.

2.55
+0.05  (2%)
Previous Close 2.50
Open 2.50
Price To book 0.86
Market Cap 23.16M
Shares 9,082,000
Volume 40,152
Short Ratio 3.31
Av. Daily Volume 31,698

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b interim analysis due 3Q 2017.
Gencaro - GENETIC-AF trial
Chronic Heart Failure

Latest News

  1. ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
  2. Anders Hove, MD Joins ARCA biopharma Board of Directors
  3. ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  4. ARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial
  5. ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
  6. ARCA BIOPHARMA TO PRESENT AT BIOTECH SHOWCASE 2017
  7. ARCA BIOPHARMA TO PRESENT AT BIOTECH SHOWCASE 2017
  8. ARCA biopharma to Present at Biotech Showcase 2017
  9. ARCA BIOPHARMA, INC. Financials
  10. StockNewsNow.com Publishes New SNNLive Video Interview with ARCA biopharma, Inc. Provides Company Overview and Discusses Clinical Development
  11. ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
  12. ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
  13. ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2016 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
  14. ARCA biopharma Announces Third Quarter 2016 Financial Results and Provides Business Update
  15. ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  16. ARCA biopharma Announces Randomization of First European Patients in GENETIC-AF Phase 2B/3 Clinical Trial
  17. ARCA biopharma Announces Randomization of First European Patients in GENETIC-AF Phase 2B/3 Clinical Trial
  18. ARCA biopharma to Present at the Dawson James Securities Second Annual Growth Stock Conference
  19. ARCA biopharma to Present at the Dawson James Securities Second Annual Growth Stock Conference
  20. ARCA biopharma Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award